Department of Surgery, McGovern Medical School at UTHealth, Houston, Texas.
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Ann Surg. 2021 Jun 1;273(6):1076-1080. doi: 10.1097/SLA.0000000000004795.
The aim of this study was to compare clinical and patient-reported outcomes of robotic versus laparoscopic ventral hernia repair (LVHR) at 1-year postoperative.
Despite a relative lack of research at low risk for bias assessing robotic ventral hernia repair (RVHR), the growth of RVHR has been rapid. We previously reported short-term results of the first randomized control trial comparing RVHR versus LVHR; there was no clear difference in clinical outcomes but increased operative time and cost with robotic repair.
Patients from a multicenter, blinded randomized control trial comparing RVHR versus LVHR were followed at 1 year. Outcomes included wound complication (surgical site infection, surgical site occurrence, wound dehiscence), hernia occurrence including recurrence and port site hernia, readmission, reoperation, and patient-reported outcomes (functional status, pain, and satisfaction with repair and cosmesis).
A total of 124 patients were randomized and 113 patients (91%; 60 robot, 53 laparoscopic) completed 1-year follow-up. Baseline demographics were similar in both groups. No differences were seen in wound complication (15% vs 15%; P = 0.899), hernia recurrence (7% vs 9%; P = 0.576), or readmission (2% vs 6%; P = 0.251). No patients underwent reoperation in the robotic arm, whereas 5 (9%) did in the laparoscopic arm (P = 0.020). No differences were seen in patient-reported outcomes. Both arms reported clinically significant improvements in functional status, low pain scores, and high satisfaction scores at 1-year post repair.
This study confirms that robotic ventral hernia repair is safe when compared to laparoscopy. Further studies are needed to confirm these findings.
本研究旨在比较机器人与腹腔镜腹侧疝修补术(LVHR)术后 1 年的临床和患者报告结局。
尽管在低偏倚风险评估机器人腹侧疝修补术(RVHR)的研究相对较少,但 RVHR 的发展速度很快。我们之前报告了比较 RVHR 与 LVHR 的首个随机对照试验的短期结果;机器人修复在临床结局方面没有明显差异,但手术时间和成本增加。
来自多中心、盲法随机对照试验的患者在术后 1 年进行随访。结局包括伤口并发症(手术部位感染、手术部位发生、伤口裂开)、疝发生包括复发和端口疝、再入院、再次手术和患者报告的结局(功能状态、疼痛以及对修复和美容的满意度)。
共有 124 名患者被随机分组,113 名患者(91%;60 名机器人,53 名腹腔镜)完成了 1 年随访。两组的基线人口统计学特征相似。两组在伤口并发症(15%比 15%;P = 0.899)、疝复发(7%比 9%;P = 0.576)或再入院(2%比 6%;P = 0.251)方面无差异。机器人组无患者再次手术,而腹腔镜组有 5 名(9%)患者再次手术(P = 0.020)。患者报告的结局无差异。两组在修复后 1 年时均报告了功能状态的显著改善、低疼痛评分和高满意度。
本研究证实机器人腹侧疝修补术与腹腔镜相比是安全的。需要进一步的研究来证实这些发现。